“BETTER OUTCOME OF HIGH-DOSE CEFTAZIDIME IN HEMATO – ONCOLOGICAL PATIENTS WITH INFECTIONS CAUSED BY EXTENSIVELY DRUG-RESISTANT PSEUDOMONAS AERUGINOSA”. Mediterranean Journal of Hematology and Infectious Diseases 15, no. 1 (December 31, 2022): e2023001. Accessed April 18, 2026. https://www.mjhid.org/mjhid/article/view/5143.